Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-bromo-5-(tert-butyl)phenol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

20942-68-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 20942-68-1 Structure
  • Basic information

    1. Product Name: 2-bromo-5-(tert-butyl)phenol
    2. Synonyms: 2-bromo-5-(tert-butyl)phenol
    3. CAS NO:20942-68-1
    4. Molecular Formula: C10H13BrO
    5. Molecular Weight: 229.11362
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 20942-68-1.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 138 °C(Press: 13 Torr)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.341±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 8.55±0.10(Predicted)
    10. CAS DataBase Reference: 2-bromo-5-(tert-butyl)phenol(CAS DataBase Reference)
    11. NIST Chemistry Reference: 2-bromo-5-(tert-butyl)phenol(20942-68-1)
    12. EPA Substance Registry System: 2-bromo-5-(tert-butyl)phenol(20942-68-1)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 20942-68-1(Hazardous Substances Data)

20942-68-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 20942-68-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,9,4 and 2 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 20942-68:
(7*2)+(6*0)+(5*9)+(4*4)+(3*2)+(2*6)+(1*8)=101
101 % 10 = 1
So 20942-68-1 is a valid CAS Registry Number.

20942-68-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-bromo-5-tert-butylphenol

1.2 Other means of identification

Product number -
Other names 5-TERT-BUTYL-2-BROMOPHENOL

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:20942-68-1 SDS

20942-68-1Relevant articles and documents

Oxygen-Doped PAH Electrochromes: Difurano, Dipyrano, and Furano-Pyrano Containing Naphthalene-Cored Molecules

Fletcher-Charles, Jack,Ferreira, Rúben R.,Abraham, Michael,Romito, Deborah,Oppel, Markus,González, Leticia,Bonifazi, Davide

supporting information, (2021/11/23)

In this work, we report the synthesis of O-doped naphthalene-based electrochromes. Exploiting the CuO-mediated Pummerer oxidative cycloetherification reaction, a series of 1,4- and 1,5-disubstituted naphthalene-cored dipyrano, difurano, and furano-pyrano polycyclic aromatic hydrocarbons (PAHs) have been prepared. Steady-state UV-Vis absorption and emission investigations showed that the spectroscopic profile strongly depends on the O-doping topology, with the dipyrano and the difurano derivatives demonstrating the most red-shifted and blue-shifted electronic transition, respectively. Computational investigations revealed that the cycloetherification reaction raises the HOMO energy level (while the LUMO remains largely unaffected), with the dipyrano derivatives displaying the highest values. Spectroelectrochemical measurements showed that, depending on the O-topology and the type of O-ring, different electrochromic responses could be obtained with colour transitions featuring high contrasts involving yellow, pink, orange or blue colours.

COMPOUNDS AND USES THEREOF

-

Page/Page column 71; 113-114, (2021/08/06)

The present disclosure features compounds useful for the treatment of BAF complex-related disorders.

Mosquito acetylcholinesterase as a target for novel phenyl-substituted carbamates

Mutunga, James M.,Ma, Ming,Chen, Qiao-Hong,Hartsel, Joshua A.,Wong, Dawn M.,Ding, Sha,Totrov, Max,Carlier, Paul R.,Bloomquist, Jeffrey R.

, (2019/05/27)

New insecticides are needed for control of disease-vectoring mosquitoes and this research evaluates the activity of new carbamate acetylcholinesterase (AChE) inhibitors. Biochemical and toxicological characterization of carbamates based on the parent stru

Synthesis of 2-arylbenzofuran-3-carbaldehydes: via an organocatalytic [3+2] annulation/oxidative aromatization reaction

Zhang, Huiwen,Ma, Chunmei,Zheng, Ziwei,Sun, Rengwei,Yu, Xinhong,Zhao, Jianhong

supporting information, p. 4935 - 4938 (2018/05/23)

A novel organocatalytic [3+2] annulation/oxidative aromatization reaction of enals with 2-halophenols or β-naphthols is reported. This process enables chemo- and regioselective access to 2-arylbenzofuran-3-carbaldehydes without the use of transition metals or strong oxidants. Preliminary mechanistic studies reveal that an unprecedented, organocatalytic, direct α-arylation pathway is involved.

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

-

Paragraph 00771, (2018/09/12)

Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.

Small Molecules Simultaneously Inhibiting p53-Murine Double Minute 2 (MDM2) Interaction and Histone Deacetylases (HDACs): Discovery of Novel Multitargeting Antitumor Agents

He, Shipeng,Dong, Guoqiang,Wu, Shanchao,Fang, Kun,Miao, Zhenyuan,Wang, Wei,Sheng, Chunquan

supporting information, p. 7245 - 7260 (2018/08/03)

p53-Murine double minute 2 (MDM2) interaction and histone deacetylases (HDACs) are important targets in antitumor drug development. Inspired by the synergistic effects between MDM2 and HDACs, the first MDM2/HDACs dual inhibitors were identified, which sho

A practical synthesis of a cis -4,5-Bis(4-chlorophenyl)imidazoline Intermediate for Nutlin analogues

Shu, Lianhe,Wang, Ping,Liu, Wen,Gu, Chen

, p. 1866 - 1869 (2013/01/15)

A practical synthesis of cis-4,5-bis(4-chlorophenyl)imidazoline, a key intermediate for Nutlin analogues, is reported. The title compound was prepared in 81-88% yield by boric acid catalyzed direct condensation of meso-bis(4-chlorophenyl)ethane-1,2-diamine with a benzoic acid. The process was successfully scaled up in a pilot plant, resulting in >15 kg of the product.

PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR

-

Page/Page column, (2013/03/26)

The present invention generally relates to a process that selectively polymerizes ethylene in the presence of an alpha-olefin, and to a metal-ligand complex (precatalyst) and catalyst useful in such processes, and to related compositions. The present invention also generally relates to ligands and intermediates useful for preparing the metal-ligand complex and to processes of their preparation.

An efficient synthetic route to novel 3-alkyl- and 3-aryl-4-iodophenols

Hermann, Gesine J.,Annis, Michael C.,Edwards, Peter D.,Corrales, Marta,Diaz, Lucia,Goodnow, Robert A.

, p. 221 - 224 (2008/12/20)

An efficient method for the preparation of novel 3-alkyl-and 3-aryl-4-iodophenols from 3-alkyl- and 3-arylphenols is described. Georg Thieme Verlag Stuttgart.

HETEROCYCLIC NON-PEPTIDE GNRH ANTAGONISTS

-

Page/Page column 65, (2008/06/13)

A compound of formula (I): wherein either B is absent and A and Z are the same or different and are each hydrogen, halogen, alkyl, hydroxy, alkoxy,-CN,-C(Rc)2OH,-N(Rd)C(=X)Rc,-C(=X)N(Rc)(Rd),-S(O)m-Rc,-N(Rc)(Rd)S(O)2,-S(O)2N(R c)(Rd),-N(Re)2, aryl optionally substituted with Ra or-O-aryl optionally substituted with Ra; or B is present and is-(CH2)n-,-C(Rb)2-or-O-, or B taken together with A or Z can be-C=C(Rb)-,-C(Rb)=C-,-CH2-CH(R b)-or-CH(Rb)-CH2-; D is-O-or-S(O) m,-; E is a bond or is-(CH2)n-,-N(R d)-,-(CH2)nN(Rd)-or-N(R d)(CH2)n-; F is-C(=X)-; G is-(CH2 )n-,-N(Rd)-,-(CH2)nN(R d)-or-N(Rd)(CH2)n; J is a bond,-O-,-N(RC)C(=X)-,-C(=X)N(Rc)-,-S(O)m,-,-N(Rc)S(O)m-,-S(O)nN(Rc)-,-N(Re)-or-N(Rg)(Rh); K is a bond, alkylene, cycloalkylene, cycloalkenylene, arylene, heterocycloalkylene, heterocycloalkylene or heteroarylene; and L is hydrogen or a terminal group; has therapeutic utility.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 20942-68-1